- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05408455
Expiratory Muscle Training in Bronchiectasis
Effect of Expiratory Muscle Training in Bronchiectasis Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Disruption of the mucociliary clearance mechanism in patients with bronchiectasis leaves the lungs vulnerable. With the accumulation of secretions, a vicious cycle of bacterial infection and inflammation begins. Intense inflammation causes damage and bronchial wall weakness. Problems arise with effective coughing. This leads to decreased clearance of secretions, resulting in decreased expiratory flow. Symptoms of bronchiectasis; often productive cough, dyspnea, fatigue and wheezing. Altered pulmonary mechanics, inadequate gas exchange, decreased muscle mass, and accompanying psychological problems can cause dyspnea and decreased exercise capacity, thus reducing quality of life. Exercise capacity may also decrease in individuals with bronchiectasis due to increased dyspnea perception and limitation of expiratory flow. The need for safe and viable exercise interventions to reduce the burden of the disease is evident in individuals with bronchiectasis. Respiratory muscle training is applied by using skeletal muscle training principles in order to increase respiratory muscle strength and endurance, to correct the length-tension relationship of respiratory muscles and to increase respiratory capacity. Decreased expiratory muscle strength is associated with decreased quality of life and exercise tolerance. In addition, in a study, it was shown that in addition to expiratory muscle weakness, expiratory muscle endurance decreases in respiratory patients. This decrease is closely related to the severity of airway obstruction and the decrease in the strength of other muscle groups.
In order to meet the increased metabolic needs during exercise and to keep gas exchange at a sufficient level, patients with bronchiectasis; they must increase minute ventilation as appropriate. These patients with expiratory flow limitation at rest breathe at higher lung volumes to increase ventilation during exercise, and as a result, adverse conditions such as worsening of dynamic hyperinflation, increased intrinsic PEEP, increased workload on respiratory muscles and dyspnea are observed. As a result, these patients cannot achieve high levels of tidal volume and ventilation. In addition, significantly reduced maximal voluntary ventilation in patients with flow-limited bronchiectasis; It is also related to airway obstruction and mechanical deterioration. Decreased exercise capacity has also been shown to be associated with peak exercise desaturation. Those with abnormal lung mechanics (low FEV1, FVC, and tidal expiratory flow limitation) and high dyspnea score measured by MRC reflect a decrease in exercise capacity. In a study in bronchiectasis, maximal inspiratory and maximal expiratory respiratory muscle strengths evaluated with an intraoral pressure measurement device had similar demographic characteristics. significantly lower than in healthy individuals. However, in the respiratory muscle trainings, inspiratory muscle training was emphasized and expiratory muscle training was never given.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Denizli, Turkey, 20020
- Pamukkale University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinically stable patients who do not meet the definition of exacerbation,
- Those with a diagnosis of non-CF bronchiectasis,
- Patients are between the ages of 18-70
- Patients without acute and/or chronic respiratory failure,
- Patients who do not have any contraindications for the physiotherapy method to be applied.
Exclusion Criteria:
- Those with a history of pneumothorax,
- Patients younger than 18 years
- Patients older than 70 years
- Presence of cor pulmonale and/or heart failure,
- Patients with hemoptysis,
- Those with a recent history of acute myocardial infarction,
- Presence of spinal cord injury,
- Those with unstable intervertebral disc, rib fracture,
- Patients with severe osteoporosis,
- Those who had an infective exacerbation during the physiotherapy application period,
- Those who are found to have respiratory distress that will require hospitalization,
- If there is a wound in the application area,
- If there is infection or hemorrhage in the application area
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EMST (Expiratory Muscle Streght Training) group
EMST at a pressure value between 50-75% will be applied for 8 weeks, 3 days a week and 24 sessions in total.
|
Respiratory exercise device (Expiratory muscle trainer) developed for the expiratory muscles, and resistant expiratory muscle training were applied.
Threshold loading was applied to the cases at approximately 30% of the respiratory muscle strength values measured in the 1st week.
In respiratory muscle training, the pressure value was increased according to the tolerance of the patient and training was given at a pressure value between 50-75%.
The subjects were asked to do 10 vigorous expirations at the adjusted pressure value by doing normal inspiration for expiratory muscle training in a comfortable sitting position.
This program was applied in 3 sets in the same way for approximately 30 minutes.
It was continued 3 days a week for 8 weeks
|
|
Sham Comparator: Sham EMST Group
EMST without threshold loading will be applied for 8 weeks, 3 days a week and 24 sessions in total.
|
The subjects were asked to perform normal inspiration and then exhale 10 times for expiratory muscle training without threshold loading.
This program was applied in 3 sets in the same way for approximately 30 minutes.
It will continue 3 days a week for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-minute walk test
Time Frame: Baseline to 8 weeks
|
Exercise capacity using 6-minute walk test
|
Baseline to 8 weeks
|
|
Cough strength
Time Frame: Baseline to 8 weeks
|
Cough strength using PEF meter
|
Baseline to 8 weeks
|
|
Respiratory muscle strength
Time Frame: Baseline to 8 weeks
|
Respiratory muscle strength is measured through maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using cosmed pony fx.
|
Baseline to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leicester Cough Questionnaire
Time Frame: Baseline to 8 weeks
|
Health related quality of life is assessed with Leicester Cough Questionnaire.
The total score range is 3-21 and domain scores range from 1-7; a higher score indicates a better quality of life.
|
Baseline to 8 weeks
|
|
Modified Medical Research Council Dyspnea Scale (MMRC)
Time Frame: Baseline to 8 weeks
|
Dyspnea severity is assessed with The Modified Medical Research Council Dyspnea Scale (MMRC).The mMRC scale is a self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4: 0, no breathlessness except on strenuous exercise; 4, too breathless to leave the house, or breathless when dressing or undressing.
|
Baseline to 8 weeks
|
|
Bronchiectasis Severity Index
Time Frame: Baseline to 8 weeks
|
Severity of disease is assessed with Bronchiectasis Severity Index.
The total score is calculated by summing the scores for each variable and can range from 0 to 26 points.
According to the overall score, patients are classified into three classes: patients with low BSI score (0-4 points), intermediate BSI score (5-8 points), high BSI score (≥9 points).
|
Baseline to 8 weeks
|
|
St. George's Respiratory Questionnaire (SGRQ)
Time Frame: Baseline to 8 weeks
|
Health related quality of life is assessed with St. George's Respiratory Questionnaire (SGRQ).SGRQ scores range from 0 to 100, with higher scores indicating worse quality of life.
|
Baseline to 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ayşenur yılmaz, MSc Pt, Pamukkale University
- Study Director: orçin telli atalay, Doç, Pamukkale University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 646873
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiectasis
-
Assiut UniversityNot yet recruitingBronchiectasis | Bronchiectasis Adult | Non-cystic Fibrosis Bronchiectasis | Bronchiectasis With Acute ExacerbationEgypt
-
Assiut UniversityRecruitingBronchiectasis | Non-cystic Fibrosis Bronchiectasis | Bronchiectasis With Acute ExacerbationEgypt
-
Assiut UniversityRecruitingBronchiectasis | Non-cystic Fibrosis Bronchiectasis | Bronchiectasis With Acute ExacerbationEgypt
-
SanofiRecruitingNon-cystic Fibrosis BronchiectasisUnited States
-
Alexandria UniversityCompletedBronchiectasis Adult | Bronchiectasis with Acute ExacerbationEgypt
-
Assiut UniversityNot yet recruitingBronchiectasis, Non-Cystic FibrosisEgypt
-
Indiana UniversityNot yet recruitingIdiopathic Bronchiectasis
-
The First Affiliated Hospital with Nanjing Medical...CompletedBronchiectasis Adult | RadiomicsChina
-
Ruijin HospitalNot yet recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingBronchiectasis AdultChina
Clinical Trials on EMST150 (Expiratory muscle training)
-
Sunnybrook Health Sciences CentreWithdrawnSlow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term CareCough | Dysphagia | Aging | Aspiration Pneumonia | Dysphagia, Oropharyngeal | Dysphagia, ProgressiveCanada
-
University of CalgaryMuscular Dystrophy CanadaEnrolling by invitationMuscular Dystrophies | Oculopharyngeal Muscular Dystrophy | Myopathy; HereditaryCanada
-
Medical University of South CarolinaCompleted
-
Istinye UniversityNot yet recruitingCerebral Palsy (CP)
-
National Taiwan University HospitalNot yet recruitingParkinson Disease | Pulmonary Disease | Voice Disorders
-
General University Hospital, PragueRecruiting
-
General University Hospital, PragueRecruitingParkinson Disease | mHealth | Voluntary Peak Cough StrengthCzechia
-
Noel JabbourNational Institute on Deafness and Other Communication Disorders (NIDCD)TerminatedCleft Palate | Tube Disorders Eustachian | Velopharyngeal Incompetence Due to Cleft Palate | Velopharyngeal InsufficiencyUnited States
-
Gazi UniversityRecruitingAdolescent DevelopmentTurkey
-
University of SalamancaNot yet recruitingMuscle Weakness | Acquired Brain Injury | Respiratory Disease | Physical Inactivity | Older People--Abuse of